TABLE 2.
Distribution of phenotypes among invasive serogroup W135 strains isolated in France in 2001 and 2002
| Phenotypea | No. of isolates
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | Total | |
| 2a:P1.5,2 | 0 | 0 | 1 | 2 | 2 | 2 | 25 | 16 | 12 | 60 |
| 2a:NST | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 1 | 3 | 8 |
| 2a:P1.2 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 8 | 6 | 20 |
| 2a:P1.5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| NT:P1.2 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 4 |
| NT:P1.5 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 7 | 10 |
| NT:P1.5,2 | 0 | 0 | 2 | 2 | 0 | 1 | 3 | 1 | 1 | 10 |
| 15:P1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 15:P1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
| 2b:NST | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2b:P1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| NT:P1.1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 |
| NT:P1.4 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 3 |
| NT:P1.6 | 0 | 1 | 6 | 0 | 0 | 4 | 7 | 8 | 13 | 39 |
| NT:P1.7 | 0 | 1 | 1 | 0 | 1 | 0 | 4 | 1 | 1 | 9 |
| NT:P1.16 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 4 |
| NT:NST | 0 | 1 | 1 | 1 | 3 | 5 | 5 | 6 | 8 | 30 |
| Total | 1 (1)b | 3 (3) | 13 (7) | 6 (4) | 10 (5) | 16 (7) | 55 (10) | 43 (9) | 58 (14) | 205 |
a
Phenotypes are presented as the serogroup:serotype:serosubtype.
b
The values in parentheses are the members of different phenotypes.